Researchers probe potential role of Ozempic, other weight-loss drugs in vision loss

Physician–scientists at the University of Utah’s John A. Moran Eye Center have published an investigatory review of nine patients who experienced vision complications while taking popular semaglutide and tirzepatide drugs prescribed for diabetes and weight loss.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup